Digipath, Inc. Appoints John Abroon as Initial Member of Advisory Board
May 03, 2017 at 09:00 am
Share
Digipath, Inc. announced that it has appointed John Abroon, M.D. as the initial member of its Advisory Board. Abroon is a board-certified general practitioner who specializes in diagnostic and preventative medicine, completing his residency program at Westchester County Medical Center in 1986. He completed three years of research in liver diseases, and has published a number of articles on liver cirrhosis in The American Journal of Gastroenterology and the Journal of Hepatology.
Hypha Labs, Inc., formerly Digipath, Inc., has developed technology that cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. This product has an exact, consistent potency containing all the natural compounds found in these fungi. Typically, it takes six-eight weeks to fully grow mushrooms, and using its technology, the production of the active ingredient is only seven-10 days. This natural product solves the dosing issue created by having to use whole mushrooms. The product is tasteless and gentler on the stomach and can be used sublingually for fast-acting results. The product allows the consumer to produce measurable active ingredients at home for mental and physical benefits. It provides Psilocybin Mushrooms, Button Mushrooms, Shiitake Mushrooms, Maitake Mushrooms, Reishi Mushrooms, Lion's Mane Mushrooms, Oyster Mushrooms, Oyster Mushrooms and Crimini Mushrooms.